Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.7, 2008-05, pp. : 1229-1236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1

By McKiernan Patrick J.

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 743-750

Adis International

Access to resources Recommend Favorite

Sleeping Beauty Transposon System is a Reliable Gene Delivery Tool for Hereditary Tyrosinaemia Type 1 Disease Gene Therapy: Size of the Foreign Gene Decides the Timing of Stable Integration into the Host Chromosomes

By Pan X-J Ma Z-Z Zhang Q-J Fan L Li Q-H

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1850-1859

Field House Publishing

Access to resources Recommend Favorite

Current Strategies for the Treatment of Hereditary Tyrosinemia Type I

By Ashorn Merja

Pediatric Drugs, Vol. 8, Iss. 1, 2006-01 ,pp. : 47-54

Adis International

Access to resources Recommend Favorite

Pharmacological Treatment of Endometriosis: Experience with Aromatase Inhibitors

By Ferrero Simone

Drugs, Vol. 69, Iss. 8, 2009-06 ,pp. : 943-952

Adis International

Access to resources Recommend Favorite

Pharmacological and clinical experience in nefazodone treatment of depression

By Preakorn S.H.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 249-250

Elsevier

Access to resources Recommend Favorite